S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(-0.10%) $79.98
Gas
(1.37%) $2.66
Gold
(0.87%) $2 438.40
Silver
(4.10%) $32.54
Platinum
(0.95%) $1 100.40
USD/EUR
(-0.03%) $0.920
USD/NOK
(-0.06%) $10.67
USD/GBP
(0.03%) $0.787
USD/RUB
(0.09%) $91.05

Realtime updates for Johnson & Johnson [JNJ.DE]

Exchange: XETRA Sector: Pharmaceuticals Industry: Drug Manufacturers—General
Last Updated17 May 2024 @ 11:35

0.55% 141.52

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide...

Stats
Today's Volume 2 767.00
Average Volume 3 372.00
Market Cap 340.59B
EPS €0 ( 2024-04-15 )
Next earnings date ( €0 ) 2024-07-16
Last Dividend €1.190 ( 2023-08-25 )
Next Dividend €0 ( N/A )
P/E 22.83
ATR14 €0.252 (0.18%)

Volume Correlation

Long: -0.03 (neutral)
Short: 0.19 (neutral)
Signal:(42.172) Neutral

Johnson & Johnson Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Johnson & Johnson Correlation - Currency/Commodity

The country flag 0.55
( weak )
The country flag -0.26
( neutral )
The country flag 0.34
( neutral )
The country flag 0.56
( weak )
The country flag -0.12
( neutral )
The country flag -0.28
( neutral )

Johnson & Johnson Financials

Annual 2023
Revenue: €85.16B
Gross Profit: €58.61B (68.82 %)
EPS: €13.88
FY 2023
Revenue: €85.16B
Gross Profit: €58.61B (68.82 %)
EPS: €13.88
FY 2022
Revenue: €94.94B
Gross Profit: €63.85B (67.26 %)
EPS: €6.86
FY 2021
Revenue: €93.78B
Gross Profit: €63.92B (68.16 %)
EPS: €7.93

Financial Reports:

No articles found.

Johnson & Johnson Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€1.130
(N/A)
€1.130
(N/A)
€1.130
(N/A)
€1.190
(N/A)
€1.190
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Johnson & Johnson Dividend Information - Ex Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.52 - Increase likely (50.32%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.415 2008-02-22
Last Dividend €1.190 2023-08-25
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 65 --
Total Paid Out €56.18 --
Avg. Dividend % Per Year 0.00% --
Score 5.02 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.52
Div. Directional Score 9.56 --
Next Divdend (Est)
(2024-07-01)
€1.211 Estimate 22.50 %
Dividend Stability
0.60 Above Average
Dividend Score
5.02
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
NKE.DE Ex Dividend King 2023-09-01 Quarterly 0 0.00%
ECGF.F Ex Dividend Junior 2023-09-14 Semi-Annually 0 0.00%
PUM.DE Ex Dividend Junior 2023-05-25 Annually 0 0.00%
2GB.DE Ex Dividend Junior 2023-06-14 Annually 0 0.00%
H5E.DE No Dividend Player 2023-07-10 Annually 0 0.00%
TR9.F No Dividend Player 2023-07-21 Annually 0 0.00%
AISF.F Ex Dividend Knight 2023-08-18 Semi-Annually 0 0.00%
KLA.DE Ex Dividend Knight 2023-08-14 Quarterly 0 0.00%
CAT1.DE Ex Dividend Knight 2023-07-19 Quarterly 0 0.00%
MUB.DE Ex Dividend Junior 2023-08-11 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.4291.5001.4172.13[0 - 0.5]
returnOnAssetsTTM0.2241.2002.543.05[0 - 0.3]
returnOnEquityTTM0.5401.5005.117.67[0.1 - 1]
payoutRatioTTM0.304-1.0006.96-6.96[0 - 1]
currentRatioTTM1.1700.8009.157.32[1 - 3]
quickRatioTTM0.8450.8009.747.79[0.8 - 2.5]
cashRatioTTM0.5231.5008.2110.00[0.2 - 2]
debtRatioTTM0.196-1.5006.74-10.00[0 - 0.6]
interestCoverageTTM34.721.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM9.632.006.7910.00[0 - 30]
freeCashFlowPerShareTTM7.572.006.2110.00[0 - 20]
debtEquityRatioTTM0.480-1.5008.08-10.00[0 - 2.5]
grossProfitMarginTTM0.6861.0001.8951.895[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.546.54[0.1 - 0.6]
cashFlowToDebtRatioTTM0.6901.0007.287.28[0.2 - 2]
assetTurnoverTTM0.5210.8009.867.89[0.5 - 2]
Total Score11.61

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM9.631.0009.130[1 - 100]
returnOnEquityTTM0.5402.506.867.67[0.1 - 1.5]
freeCashFlowPerShareTTM7.572.007.4810.00[0 - 30]
dividendYielPercentageTTM3.091.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM9.632.006.7910.00[0 - 30]
payoutRatioTTM0.3041.5006.96-6.96[0 - 1]
pegRatioTTM6.901.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2591.0006.030[0.1 - 0.5]
Total Score7.52

Johnson & Johnson Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators